Sort
82,697 grants matching “vaccine development”
Center for Human Immunology
$3,697,012Katherine Stagliano · National Institute Of Allergy And Infectious Diseases · ZIC · FY2018 · AI
MICROBIOLOGY AND INFECTIOUS DISEASES BIOLOGICAL RESEARCH REPOSITORY (MID BRR) - SARS-CoV-2 VACCINE RESEARCH RELATED ACTIVITIES
$3,696,409Timothy Stedman · American Type Culture Collection · N01 · FY2022 · AI
Leveraging genomic data to dissect the association of internalizing disorders with the risk, onset, and vulnerability of COVID-19
$3,694,722Renato Polimanti · Yale University · RF1 · FY2022 · MH
DEVELOPMENT OF VACCINES FOR INFLUENZA USING AN IMMUNO-MODULATOR ADJUVANT AND MULTI-PLATFORM APPROACH
$3,691,826Bruxanne El-Kammash · University Of Chicago · N01 · FY2024 · AI
University of Pennsylvania HIV Clinical Trials Unit
$3,690,931Ian Frank · University Of Pennsylvania · UM1 · FY2021 · AI
A Phase I/IIa Clinical Trial Testing the Safety and Immunogenicity of a Heroin Vaccine and its Efficacy Against Morphine Challenge.
$3,690,224Gary R. Matyas · Henry M. Jackson Fdn For The Adv Mil/Med · UG3 · FY2018 · DA
FEND for TB
$3,689,474Jerrold J. Ellner · Rutgers Biomedical And Health Sciences · U01 · FY2024 · AI
Cleaved, stabilized HIV-1 Env trimers for structural and vaccine studies
$3,689,011John P Moore · Weill Medical Coll Of Cornell Univ · P01 · FY2023 · AI
Cleaved, stabilized HIV-1 Env trimers for structural and vaccine studies
$3,689,011John P Moore · Weill Medical Coll Of Cornell Univ · P01 · FY2024 · AI
Mechanisms of protective immunity induced by live attenuated SIV vaccines
$3,688,528R. Paul Johnson · Harvard Medical School · P01 · FY2007 · AI
Optimizing validity of comparative effectiveness research in Alzheimer's disease and related dementias using large language models
$3,687,278Joshua K Lin · Brigham And Women'S Hospital · RF1 · FY2025 · AG
Project 2. cGMP manufacture of HIV-1 Env trimer sortase A-conjugated nanoparticles
$3,682,416Jason Dickens · Duke University · U19 · FY2024 · AI
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
$3,677,926Cheryl L Willman · University Of New Mexico Health Scis Ctr · U2C · FY2022 · CA
Multicenter AIDS Cohort Study
$3,677,363Charles R Rinaldo · University Of Pittsburgh At Pittsburgh · U01 · FY2010 · AI
Advanced Development and Clinical Evaluation of an Entamoeba histolytica Vaccine
$3,674,481Christopher Fox · Access To Advanced Health Institute · N01 · FY2022 · AI
Multicenter AIDS Cohort Study
$3,673,937Charles R Rinaldo · University Of Pittsburgh At Pittsburgh · U01 · FY2009 · AI
MAINTENANCE OF A CLOSED CPRC SPF COLONY
$3,673,219Carlos A Sariol · University Of Puerto Rico Med Sciences · U42 · FY2023 · OD
University of Washington Center for Aids Research
$3,673,055King Kennard Holmes · University Of Washington · P30 · FY2015 · AI
MAINTENANCE OF A CLOSED CPRC SPF COLONY
$3,670,641Carlos A Sariol · University Of Puerto Rico Med Sciences · U42 · FY2020 · OD
Viral Hemorrhagic Fevers: Disease Modeling and Transmission
$3,668,794Heinrich Feldmann · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
MAINTENANCE OF A CLOSED CPRC SPF COLONY
$3,668,044Carlos A Sariol · University Of Puerto Rico Med Sciences · U42 · FY2022 · OD
UZ-UCSF CTU
$3,668,011Zvavahera Mike Chirenje · University Of California, San Francisco · UM1 · FY2024 · AI
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: CLINICAL CORE
$3,667,392Emmanuel Walter · Duke University · N01 · FY2021 · AI
Novel VLP-Based Mucosal and Sytemic HIV Vaccines
$3,665,980Jiri F Mestecky · University Of Alabama At Birmingham · U19 · FY2006 · AI
Biomarkers and Mechanisms of Paucibacillary and Latent Tuberculosis
$3,665,571Jerrold J. Ellner · Rbhs-New Jersey Medical School · U19 · FY2019 · AI